Results 31 to 40 of about 351,379 (204)

The effects of specific expression of apoptin under the control of PSES and PSA promoter on cell death and apoptosis of LNCaP cells [PDF]

Iranian Journal of Basic Medical Sciences, 2017
Objective(s): Apoptotic effect of apoptin has been demonstrated in numerous studies. However, its tumor specificity has been questioned by some reports.
Vida Mohammadi, Abbas Behzad Behbahani, Gholam Reza Rafiee, Seyed Younes Hosseini, Marzieh Alizadeh Zarei, Mohammad Ali Okhovat, Mohammad Ali Takhshid   +6 more
doaj   +1 more source

The diagnostic value of a new formula combining age and prostate volume in prostate cancer

Journal of Men's Health, 2022
Background and objective: This study combined two clinical indicators (age and prostate volume (PV)) to generate age to PV (AVR) ratio, whose diagnostic value for prostate cancer (PCa) was examined based on prostate specific antigen (PSA) in the range
Xiaobo Yang, Jiahao Shan, Qiang Zhang, Zhongyu Yuan, Haoran Xu, Ziyang Liu, Xiaojie Zhou, Wenzhuo Ma, Hongbin Shi   +8 more
doaj   +1 more source

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies

Journal of Experimental & Clinical Cancer Research, 2010
Background The present study was undertaken to relate the co-expression of prostate-associated antigens, PSMA and PSA, with the degree of vascularization in normal and pathologic (hyperplasia and cancer) prostate tissues to elucidate their possible role ...
Nouira Yassin, Ouertani Latifa, Rais Nawfel, Banasr Ahmed, Sallami Sataa, Bouraoui Yosra, Ben Jemaa Awatef, Horchani Ali, Oueslati Ridha   +8 more
doaj   +1 more source

Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998–2017 [PDF]

, 2021
Background: Prostate cancer is a leading cause of cancer-related death. Interpretation of results from trials of screening with prostate-specific antigen (PSA) are complex in terms of defining optimal prostate cancer screening policy.Aims: Assess the ...
Coupland, Carol A.C., Hippisley-Cox, Julia, Clift, Ashley, Coupland, Carol AC, Clift, Ashley Kieran   +4 more
core   +2 more sources

Evaluation of Prostate specific antigen levels and its correlation with histopathological findings

Journal of Pathology of Nepal, 2019
Background: Prostate specific antigen is a tumor marker though is expressed by both normal and neoplastic prostate tissue. The absolute value of Prostate specific antigen is useful for determining the extent of prostate cancer and its treatment. Prostate
Sujata Pudasaini, Neeraj Subedi, Nagesh Mani Shrestha   +2 more
doaj   +1 more source

Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population

Indian Journal of Urology, 2007
Introduction: We sought to determine the distribution of serum prostate specific antigen (PSA) levels in a community-based population in the state of Gujarat in India.
Arvind P Ganpule, Mahesh R Desai, T Manohar, Sharad Bapat   +3 more
doaj   +1 more source

The Impact of Interscreening Interval and Age on Prostate Cancer Screening With Prostate-Specific Antigen [PDF]

, 2014
Background: Population-based screening for prostate cancer (PCa) has used serum prostate-specific antigen (PSA) since the early 1990s. However, the efficacy could be affected by screening interval, age ranges of screening, attendance, and contamination ...
Wu, Grace Hui-Min;Auvinen, Anssi;Yen, Amy Ming-Fang;Hakama, Matti;Tammela, Teuvo L.;Stenman, Ulf-Hakan;Kujala, Paula;Ruutu, Mirja;Chen, Hsiu-Hsi, 陳秀熙   +1 more
core   +1 more source

Prostate specific antigen criteria to diagnose failure of cancer control following focal therapy of nonmetastatic prostate cancer using high Intensity focused ultrasound [PDF]

, 2020
PURPOSE: We determined whether prostate specific antigen criteria after focal high intensity focused ultrasound to treat prostate cancer could diagnose treatment failure.
Persad, Raj, Hosking-Jervis, Feargus, Huber, Philipp Markus, Afzal, N, Odgen, C, Persad, R, Moore, CM, Afzal, Naveed, Ahmed, Hashim U, Huber, PM, Thalmann, George N, Guillaumier, S, Boxler, S, Nigam, R, Emberton, M, Hindley, RG, Huber, Philipp M, Leemann, Lucas, Hosking-Jervis, F, Emberton, Mark, Winkler, M, Dudderidge, T, Virdi, Jaspal, Virdi, J, Hindley, Richard G, Lewi, Henry, Moore, Caroline M, Boxler, Silvan, Dudderidge, Tim, Leemann, L, McCartan, Neil, Odgen, Chris, Guillaumier, Stephanie, Nigam, Raj, Arya, Manit, Winkler, Mathias, Arya, M, Ahmed, HU, Thalmann, GN, Lewi, H, McCartan, N, Thalmann, George   +41 more
core   +1 more source

Developing recombinant overlapping peptides of prostate-specific antigen as vaccine [PDF]

, 2023
Immunotherapy has become a new approach for prostate cancer (PCa) due to its selectivity and efficacy. With immunogenic properties, PSA has been found to be overexpressed in PCa and its enzymatic activity enhances the growth and progression of PCa cells.
Chan, Song
core   +2 more sources

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan

Asian Journal of Andrology, 2014
To clarify the recent trends in prostate-specific antigen (PSA) distribution in men in Japan, we analyzed the PSA distributions of men undergoing PSA-based population screening.
Yasuhide Kitagawa, Kazuaki Machioka, Hiroshi Yaegashi, Kazufumi Nakashima, Mitsuo Ofude, Kouji Izumi, Satoru Ueno, Yoshifumi Kadono, Hiroyuki Konaka, Atsushi Mizokami, Mikio Namiki   +10 more
doaj   +1 more source